Back to Treatments

Treatment

Venetoclax + Azacitidine

1
Conditions
253
Trials
2,000
Participants
35%
Average Safety

Condition Evidence

Acute myeloid leukemia

253 trials · 2,000 participants

80% effectiveness · 35% safety
Venetoclax + Azacitidine | DFDA